Literature DB >> 18042398

Plasminogen activator induction facilitates recovery of respiratory function following spinal cord injury.

Kenneth H Minor1, Nicholas W Seeds.   

Abstract

The possibility that plasminogen activator (PA) plays a role in synaptic plasticity was explored in the spinal cord during the crossed phrenic phenomenon (CPP), where respiratory functional plasticity develops following spinal cord injury. Synaptic remodeling on phrenic motorneurons occurs during the characteristic delay period following spinal cord injury before CPP recovery of respiratory function. The molecular mechanisms underlying this plasticity are not well-defined. During the critical 1-2 h delay period required for this synaptic plasticity following a C2 hemisection in mice, uPA and tPA mRNAs are rapidly induced in C4-5 ventral spinal cord neurons in the ipsilateral phrenic motor nucleus (PMN), as are uPA and tPA protein levels. A role for uPA in CPP spinal cord plasticity is confirmed by the impaired ability of uPA knockout mice to acquire a good CPP response by 6 h post-hemisection and their lack of structural remodeling of PMN synapses that underlies development of the CPP response.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18042398     DOI: 10.1016/j.mcn.2007.09.005

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  11 in total

1.  Axonal regrowth after spinal cord injury via chondroitinase and the tissue plasminogen activator (tPA)/plasmin system.

Authors:  Noreen Bukhari; Luisa Torres; John K Robinson; Stella E Tsirka
Journal:  J Neurosci       Date:  2011-10-19       Impact factor: 6.167

2.  Plasminogen activator promotes recovery following spinal cord injury.

Authors:  Nicholas Seeds; Steve Mikesell; Rebekah Vest; Thomas Bugge; Kristin Schaller; Kenneth Minor
Journal:  Cell Mol Neurobiol       Date:  2011-05-14       Impact factor: 5.046

3.  The phrenic motor nucleus in the adult mouse.

Authors:  K Qiu; M A Lane; K Z Lee; P J Reier; D D Fuller
Journal:  Exp Neurol       Date:  2010-09-15       Impact factor: 5.330

4.  Anatomical Recruitment of Spinal V2a Interneurons into Phrenic Motor Circuitry after High Cervical Spinal Cord Injury.

Authors:  Lyandysha V Zholudeva; Jordyn S Karliner; Kimberly J Dougherty; Michael A Lane
Journal:  J Neurotrauma       Date:  2017-06-29       Impact factor: 5.269

5.  Transcriptional activation of endothelial cells by TGFβ coincides with acute microvascular plasticity following focal spinal cord ischaemia/reperfusion injury.

Authors:  Richard L Benton; Melissa A Maddie; Toros A Dincman; Theo Hagg; Scott R Whittemore
Journal:  ASN Neuro       Date:  2009-08-26       Impact factor: 4.146

Review 6.  The crossed phrenic phenomenon and recovery of function following spinal cord injury.

Authors:  Harry G Goshgarian
Journal:  Respir Physiol Neurobiol       Date:  2009-06-17       Impact factor: 1.931

7.  Transcriptomic screening of microvascular endothelial cells implicates novel molecular regulators of vascular dysfunction after spinal cord injury.

Authors:  Richard L Benton; Melissa A Maddie; Christopher A Worth; Edward T Mahoney; Theo Hagg; Scott R Whittemore
Journal:  J Cereb Blood Flow Metab       Date:  2008-07-09       Impact factor: 6.200

Review 8.  Role of plasminogen activator in spinal cord remodeling after spinal cord injury.

Authors:  Nicholas W Seeds; Lisa Akison; Kenneth Minor
Journal:  Respir Physiol Neurobiol       Date:  2009-08-03       Impact factor: 1.931

Review 9.  Respiratory neuroplasticity and cervical spinal cord injury: translational perspectives.

Authors:  Michael A Lane; David D Fuller; Todd E White; Paul J Reier
Journal:  Trends Neurosci       Date:  2008-09-03       Impact factor: 13.837

10.  The effect of pharmacological inhibition of Serine Proteases on neuronal networks in vitro.

Authors:  Sebastiaan Van De Vijver; Stephan Missault; Jeroen Van Soom; Pieter Van Der Veken; Koen Augustyns; Jurgen Joossens; Stefanie Dedeurwaerdere; Michele Giugliano
Journal:  PeerJ       Date:  2019-04-23       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.